130 related articles for article (PubMed ID: 24534486)
1. 2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors.
Costales A; Mathur M; Ramurthy S; Lan J; Subramanian S; Jain R; Atallah G; Setti L; Lindvall M; Appleton BA; Ornelas E; Feucht P; Warne B; Doyle L; Basham SE; Aronchik I; Jefferson AB; Shafer CM
Bioorg Med Chem Lett; 2014 Mar; 24(6):1592-6. PubMed ID: 24534486
[TBL] [Abstract][Full Text] [Related]
2. Substituted indolin-2-ones as p90 ribosomal S6 protein kinase 2 (RSK2) inhibitors: Molecular docking simulation and structure-activity relationship analysis.
Zhong Y; Xue M; Zhao X; Yuan J; Liu X; Huang J; Zhao Z; Li H; Xu Y
Bioorg Med Chem; 2013 Apr; 21(7):1724-34. PubMed ID: 23434140
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 2-substituted benzoxazoles as novel PTP1B inhibitors.
Chandrasekharappa AP; Badiger SE; Dubey PK; Panigrahi SK; Manukonda SR
Bioorg Med Chem Lett; 2013 May; 23(9):2579-84. PubMed ID: 23528300
[TBL] [Abstract][Full Text] [Related]
4. Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.
Li S; Zhou Y; Lu W; Zhong Y; Song W; Liu K; Huang J; Zhao Z; Xu Y; Liu X; Li H
J Chem Inf Model; 2011 Nov; 51(11):2939-47. PubMed ID: 21995341
[TBL] [Abstract][Full Text] [Related]
5. Substituted pteridinones as p90 ribosomal S6 protein kinase (RSK) inhibitors: A structure-activity study.
Casalvieri KA; Matheson CJ; Backos DS; Reigan P
Bioorg Med Chem; 2020 Mar; 28(5):115303. PubMed ID: 31982240
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, activity evaluation, and docking analysis of barbituric acid aryl hydrazone derivatives as RSK2 inhibitors.
Xue M; Xu M; Lu W; Huang J; Li H; Xu Y; Liu X; Zhao Z
J Enzyme Inhib Med Chem; 2013 Aug; 28(4):747-52. PubMed ID: 22545939
[TBL] [Abstract][Full Text] [Related]
7. 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors.
Gerspacher M; Furet P; Pissot-Soldermann C; Gaul C; Holzer P; Vangrevelinghe E; Lang M; Erdmann D; Radimerski T; Regnier CH; Chene P; De Pover A; Hofmann F; Baffert F; Buhl T; Aichholz R; Blasco F; Endres R; Trappe J; Drueckes P
Bioorg Med Chem Lett; 2010 Mar; 20(5):1724-7. PubMed ID: 20138510
[TBL] [Abstract][Full Text] [Related]
8. Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivity.
Kirrane TM; Boyer SJ; Burke J; Guo X; Snow RJ; Soleymanzadeh L; Swinamer A; Zhang Y; Madwed JB; Kashem M; Kugler S; O'Neill MM
Bioorg Med Chem Lett; 2012 Jan; 22(1):738-42. PubMed ID: 22056746
[TBL] [Abstract][Full Text] [Related]
9. Indole RSK inhibitors. Part 1: discovery and initial SAR.
Boyer SJ; Burke J; Guo X; Kirrane TM; Snow RJ; Zhang Y; Sarko C; Soleymanzadeh L; Swinamer A; Westbrook J; Dicapua F; Padyana A; Cogan D; Gao A; Xiong Z; Madwed JB; Kashem M; Kugler S; O'Neill MM
Bioorg Med Chem Lett; 2012 Jan; 22(1):733-7. PubMed ID: 22100312
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel benzoxazole analogs as Aurora B kinase inhibitors.
An Y; Lee E; Yu Y; Yun J; Lee MY; Kang JS; Kim WY; Jeon R
Bioorg Med Chem Lett; 2016 Jul; 26(13):3067-3072. PubMed ID: 27209235
[TBL] [Abstract][Full Text] [Related]
11. Reversible covalent inhibition of a protein target.
Lee CU; Grossmann TN
Angew Chem Int Ed Engl; 2012 Aug; 51(35):8699-700. PubMed ID: 22806944
[No Abstract] [Full Text] [Related]
12. Discovery of Potent and Selective RSK Inhibitors as Biological Probes.
Jain R; Mathur M; Lan J; Costales A; Atallah G; Ramurthy S; Subramanian S; Setti L; Feucht P; Warne B; Doyle L; Basham S; Jefferson AB; Lindvall M; Appleton BA; Shafer CM
J Med Chem; 2015 Sep; 58(17):6766-83. PubMed ID: 26270416
[TBL] [Abstract][Full Text] [Related]
13. Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.
Nguyen TL; Gussio R; Smith JA; Lannigan DA; Hecht SM; Scudiero DA; Shoemaker RH; Zaharevitz DW
Bioorg Med Chem; 2006 Sep; 14(17):6097-105. PubMed ID: 16723234
[TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors.
Cumming JG; Debreczeni JÉ; Edfeldt F; Evertsson E; Harrison M; Holdgate GA; James MJ; Lamont SG; Oldham K; Sullivan JE; Wells SL
J Med Chem; 2015 Jan; 58(1):278-93. PubMed ID: 25255283
[TBL] [Abstract][Full Text] [Related]
15. Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.
Martin RE; Mohr P; Maerki HP; Guba W; Kuratli C; Gavelle O; Binggeli A; Bendels S; Alvarez-Sánchez R; Alker A; Polonchuk L; Christ AD
Bioorg Med Chem Lett; 2009 Nov; 19(21):6106-13. PubMed ID: 19786348
[TBL] [Abstract][Full Text] [Related]
16. The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode.
Wrobleski ST; Lin S; Dhar TG; Dyckman AJ; Li T; Pitt S; Zhang R; Fan Y; Doweyko AM; Tokarski JS; Kish KF; Kiefer SE; Sack JS; Newitt JA; Witmer MR; McKinnon M; Barrish JC; Dodd JH; Schieven GL; Leftheris K
Bioorg Med Chem Lett; 2013 Jul; 23(14):4120-6. PubMed ID: 23746475
[TBL] [Abstract][Full Text] [Related]
17. Benzo[c][2,7]naphthyridines as inhibitors of PDK-1.
Kim KH; Wissner A; Floyd MB; Fraser HL; Wang YD; Dushin RG; Hu Y; Olland A; Guo B; Arndt K
Bioorg Med Chem Lett; 2009 Sep; 19(17):5225-8. PubMed ID: 19628388
[TBL] [Abstract][Full Text] [Related]
18. Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.
Cho SY; Han SY; Ha JD; Ryu JW; Lee CO; Jung H; Kang NS; Kim HR; Koh JS; Lee J
Bioorg Med Chem Lett; 2010 Jul; 20(14):4223-7. PubMed ID: 20570511
[TBL] [Abstract][Full Text] [Related]
19. Identifying requirements for RSK2 specific inhibitors.
Wright EB; Fukuda S; Li M; Li Y; O'Doherty GA; Lannigan DA
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1798-1809. PubMed ID: 34348556
[TBL] [Abstract][Full Text] [Related]
20. Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole.
Rigden DJ; Botzki A; Nukui M; Mewbourne RB; Lamani E; Braun S; von Angerer E; Bernhardt G; Dove S; Buschauer A; Jedrzejas MJ
Glycobiology; 2006 Aug; 16(8):757-65. PubMed ID: 16638841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
